drugset / Trial / NCT01687101

STOPAIN in the Treatment of a Single Migraine Attack

NCT01687101 ↗

Completed 32 enrolled Thomas Jefferson University
NaSingle-groupOpen-labelTreatment

Summary

This is an open label pilot study of 25 subjects with a diagnosis of episodic migraine with or without aura. STOPAIN is an over-the-counter product that is used for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains. We plan to have subjects apply the product during a single migraine attack to see if it will alleviate the headache pain and associated symptoms.

Timeline

Start
2012-05
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject STOPAIN Unknown 6 % Topical

Indications